Going for a walk outside, reading, listening to music—these and other enjoyable activities can reduce blood pressure for elderly caregivers of spouses with Alzheimer’s disease, suggests a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.
Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, and the European Hematology Association (EHA) are pleased to announce the launch a new open access journal, HemaSphere. Part of the Lippincott portfolio, the journal was launched today at the 22nd Annual Congress of the European Hematology Association in Madrid.
The Mediterranean diet, rich in plant-based foods, is associated with a variety of health benefits, including a lower incidence of dementia.
A new drug shows promise in its ability to target one of the most common and sinister mutations of acute myeloid leukemia (AML), according to researchers at the Perelman School of Medicine at the University of Pennsylvania and Penn’s Abramson Cancer Center. The Fms-like tyrosine kinase 3 (FLT3) gene mutation is a known predictor of AML relapse and is associated with short survival. In a first-in-human study, researchers treated relapsed patients with gilteritinib, an FLT3 inhibitor, and found it was a well-tolerated drug that led to frequent and more-sustained-than-expected clinical responses, almost exclusively in patients with this mutation.
A new study from the Monell Center and collaborating institutions advances understanding of how stem cells on the tongue grow into the different types of mature taste cells that detect either sweet, salty, sour, bitter, or umami. The findings may someday allow scientists to treat taste disorders, characterize new taste qualities, or even fine-tune a person’s taste perception to encourage healthier eating.
Nancy A. Hodgson, PhD, RN, FAAN, the Anthony Buividas Term Chair in Gerontology and Associate Professor of Nursing, will assume the role of Director of the University of Pennsylvania School of Nursing’s Hillman Scholars Program in Nursing Innovation on July 1, 2017.
As published in JNCCN, a Siteman Cancer Center study uncovered potential to significantly improve NCCN Guidelines-concordant care in patients with early-stage breast cancer.
— Jorge Henao-Mejia, MD, PhD, an assistant professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia, has been recognized by The Pew Charitable Trusts as one of its 22 national Pew Scholars in Biomedical Sciences.
The use of topical antibiotics can dramatically alter communities of bacteria that live on the skin, while the use of antiseptics has a much smaller, less durable impact. The study, conducted in mice in the laboratory of Elizabeth Grice, PhD, an assistant professor of Dermatology in the Perelman School of Medicine at the University of Pennsylvania, is the first to show the long-term effects of antimicrobial drugs on the skin microbiome.
The first two-part episode of Lauren Kelly, MD’s podcast, “When I Die, Let Me Live,” is not always an easy listen — but that’s kinda the point. Kelly, who graduated from the Perelman School of Medicine earlier this year, aims to present the listener with firsthand stories from patients, families, and caretakers dealing with the myriad physical, mental, emotional, and moral complexities of end-of-life care.
Overcrowding of intensive care units (ICUs) is a growing problem in American hospitals, often resulting in the need to place patients in alternate intensive care units within a hospital. Research has indicated that these “ICU boarder” patients — for example, a brain surgery patient staying in a cardiac ICU — have worse outcomes as a result of this alternate placement, and now, a new study suggests one reason for these worse outcomes is that ICU boarders, compared to non-boarders, appear to get markedly less attention from doctors and other caregivers.
On the front lines, United States service men and women serve and protect the American dream. When they return home, many desire to achieve it for themselves. At Saint Joseph’s University in Philadelphia, Pennsylvania, veterans with a desire to start their own business or venture are given the tools, confidence and opportunity to make their dreams a reality.
Larry R. Kaiser, MD, FACS, President & CEO of Temple University Health System, the Lewis Katz Dean at the Lewis Katz School of Medicine at Temple University and Senior Executive Vice President for Health Affairs at Temple University, has been named one of the top “50 Most Influential Physician Executives and Leaders” for 2017 by Modern Healthcare.
Among Medicaid patients taking opioids for chronic pain, the risk of fatal overdose rises steadily with daily opioid dose, reports a study in the July issue of Medical Care. The journal is published by Wolters Kluwer.
A new, high-resolution view of the structure of Hsp104 (heat shock protein 104), a natural yeast protein nanomachine with six subunits, may show news ways to dismantle harmful protein clumps in disease.
Researchers studying a DNA-cutting enzyme with a crucial role in regulating the structure of genes have discovered a broad role for its cutting activity in driving abnormal genetic rearrangements called translocations that cause cancer, including leukemias and solid tumors. The findings open possibilities for new clinical approaches.
Understanding and responding to behavioral trends in groups that are at high risk for HIV infection is critical to the development of effective strategies that decrease HIV incidence and improve access to care. New research based on data from the Centers for Disease Control and Prevention’s National HIV Behavioral Surveillance (NHBS) system are presented in a special supplement to JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Wolters Kluwer.
Penn winners among just 24 total recipients
The drug lenvatinib can significantly improve overall survival rates in a group of thyroid cancer patients whose disease is resistant to standard radioiodine treatment, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The study, published today in the Journal of Clinical Oncology, is the first to show lenvatinib has a definitive impact on overall survival (OS). Researchers found OS improves in patients older than 65 years of age and that the drug is well-tolerated.
Several critical periods over a human life span – including before birth -- determine when individuals are the most susceptible to environmental toxicants. Researchers will gather at the Perelman School of Medicine at the University of Pennsylvania this Monday to discuss these “Windows of Susceptibility."
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right